AstraZeneca's COVID-19 vaccine put on hold after 'unexplained illness' in clinical trial subject

AstraZeneca Plc on Tuesday said it has paused a late-stage trial of one of the leading COVID-19 vaccine candidates, being developed in collaboration with the University of Oxford, after an "unexplained illness" in a study participant.